SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) described today some of the characteristics and benefits of using the live-cell encapsulation technology that is the basis of the Company’s recently-acquired pancreatic cancer treatment.
